157 related articles for article (PubMed ID: 9692388)
1. Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder.
Bonno M; Azuma E; Kawasaki H; Zhang XL; Komada Y; Hirayama M; Higashigawa M; Umemoto M; Koike T; Kato T; Tahara T; Miyazaki H; Sakurai M
Am J Hematol; 1998 Aug; 58(4):267-72. PubMed ID: 9692388
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
3. Etiology of the myeloproliferative disorders: the role of thrombopoietin.
Kaushansky K
Semin Hematol; 2003 Jan; 40(1 Suppl 1):6-9. PubMed ID: 12682875
[TBL] [Abstract][Full Text] [Related]
4. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Griesshammer M; Bangerter M; Schrezenmeier H
Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
[TBL] [Abstract][Full Text] [Related]
5. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.
Wang JC; Hashmi G
Leuk Res; 2003 Jan; 27(1):13-7. PubMed ID: 12479847
[TBL] [Abstract][Full Text] [Related]
6. Serum thrombopoietin level and thrombocytopenia during the neonatal period in infants with Down's syndrome.
Matsubara K; Nigami H; Yura K; Inoue T; Isome K; Fukaya T
J Perinatol; 2010 Feb; 30(2):98-102. PubMed ID: 19675574
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin.
Ballmaier M; Schulze H; Strauss G; Cherkaoui K; Wittner N; Lynen S; Wolters S; Bogenberger J; Welte K
Blood; 1997 Jul; 90(2):612-9. PubMed ID: 9226161
[TBL] [Abstract][Full Text] [Related]
8. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
[TBL] [Abstract][Full Text] [Related]
9. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
10. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
[TBL] [Abstract][Full Text] [Related]
11. The role of the MPL receptor in myeloproliferative disorders.
Kaushansky K
Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development.
Sola MC; Juul SE; Meng YG; Garg S; Sims P; Calhoun DA; Dame JB; Christensen D
Early Hum Dev; 1999 Jan; 53(3):239-50. PubMed ID: 10088990
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin in patients with hepatoblastoma.
Komura E; Matsumura T; Kato T; Tahara T; Tsunoda Y; Sawada T
Stem Cells; 1998; 16(5):329-33. PubMed ID: 9766812
[TBL] [Abstract][Full Text] [Related]
14. Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.
Matsumura I; Horikawa Y; Kanakura Y
Leuk Lymphoma; 1999 Jan; 32(3-4):351-8. PubMed ID: 10037033
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression.
Nakayama H; Ihara K; Hikino S; Yamamoto J; Nagatomo T; Takemoto M; Hara T
J Mol Med (Berl); 2005 Apr; 83(4):316-20. PubMed ID: 15647951
[TBL] [Abstract][Full Text] [Related]
16. Stressful delivery influences circulating thrombopoietin (TPO) levels in newborns: possible role for cortisol in TPO-mpl binding.
Ikeno K; Koike K; Takeshita A; Shinjo K; Higuchi T; Nakabayashi T; Akanuma S; Hizume K; Ishiguro A; Ogami K; Kato T; Miyazaki H; Ohno R; Komiyama A
Early Hum Dev; 2000 Jun; 58(3):225-35. PubMed ID: 10936442
[TBL] [Abstract][Full Text] [Related]
17. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
18. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
Tamura H; Ogata K; Luo S; Nakamura K; Yokose N; Dan K; Tohyama K; Yoshida Y; Hamaguchi H; Sakamaki H; Kuwaki T; Tahara T; Kato T; Nomura T
Br J Haematol; 1998 Dec; 103(3):778-84. PubMed ID: 9858230
[TBL] [Abstract][Full Text] [Related]
19. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.
Papayannopoulou T
Cancer Chemother Pharmacol; 1996; 38 Suppl():S69-73. PubMed ID: 8765421
[TBL] [Abstract][Full Text] [Related]
20. Circulating thrombopoietin levels in neonates with infection.
Colarizi P; Fiorucci P; Caradonna A; Ficuccilli F; Mancuso M; Papoff P
Acta Paediatr; 1999 Mar; 88(3):332-7. PubMed ID: 10229048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
